Oncogenic human papillomaviruses and ploidy in cervical lesions

Journal of Clinical Pathology

Volumn 49, Issue 11, 1996, Pages 892-896

  Rihet, S ^a   Lorenzato, M ^a   Clavel, C ^a,b  

^a Department of Cardiology   (France)

^b Laboratoire Pol Bouin   (France)

Author keywords

Cervical intraepithelial neoplasia; Oncogenic human papillomavirus; Ploidy

Indexed keywords

ANEUPLOIDY; ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DYSPLASIA; WART VIRUS;

EID: 0029828080     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.11.892     Document Type: Article

References (33)

1. Zur Hausen H. Human papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancer. Virology 1991;184:9-13.
2. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavoonen J, Beckman AM, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
3. Bosch FX, Manos MM, Munoz N, Sherman MH, Jansen AM, Peto J, et al. International biological study on cervical cancer. Prevalence of human papillomavirus in cervical cancer: a worldwide prospective. J Natl Cancer Inst 1995;87:796-802.
4. Syrjänen K, Mäntyjarvi R, Väyrynan M, Syrjänen S, Parkinen S, Yliskoski M, et al. Assessing the biological potential of human papillomavirus infections in cervical carcinogenesis. In: Steinberg BM, Brandsma JL, Taichman LB eds. Papillomaviruses. Cancer Cells. Vol 5, Gold Spring Harbor: Cold Spring Harbor Laboratory Press, 1987: 281-9.
5. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-37.
6. Van den Brule AJC, Walboomers JMM, Du Maine M, Kenemans P, Meijer CJLM. Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 1991;48:404-8.
7. Cuzick J, Terry G, Ho L, Hollingsworth T, Anderson M. Human papillomavirus type 16 DNA in cervical smears as a predictor of high-grade cervical intraepithelial neoplasia. Lancet 1992;339:959-60.
8. Cox JT, Lorincz AT, Schiffman MH, Sherman MH, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-54.
9. Downey GP, Bavin PJ, Decry ARS, Crow J, Griffiths PD, Emery VC, et al. Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease. Lancet 1994;344:432-5.
10. Syrjänen KJ. Epidemiology of human papillomavirus (HPV) infections and their association with genital squamous cell cancer. APMIS 1989;97:957-70.
11. Monsonego J. Human papillomavirus (HPV), co-factors and carcinogenesis of the uterine cervix. In: Monsonego J, ed. Papillomaviruses in human pathology. Recent progress in epidermoid precancers. New York: Raven Press, 1990:31-48.
12. Remmink AJ, Walboomers JMM, Helmerhorst TJM, Voorhorst FJ, Rozendal L, Risse EKJ, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995;61:306-11.
13. De Vita R, Calugi A, Magi F, Mauro K Montevecchi L, Vecchione A. Flow cytometry DNA analysis of the human cervix affected by human papillomavirus and/or intraepithelial neoplasia. Anal Quant Cytol Histol 1990;12:306-13.
14. Dudzinski MR, Haskill SJ, Fowler WC, Currie JL. DNA content of cervical neoplasia and its relationship to prognosis. Obstet Gynccol 1987;69:373-7.
15. Hedley DW, Friedlander MI, Taylor IW, Rugg CA, Musgrove HA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-5.
16. Bibbo M, Dytch HE, Alenghat E, Bartels PH, Wied GL. DNA ploidy profiles as prognostic indicators in CIN lesions. Am J Clin Pathol 1989;92:261-5.
17. Chacho MS, Eppich E, Wersto R, Koss JG. Influence of human papillomavirus on DNA ploidy determination in genital condylomas. Cancer 1990;65:2291-4.
18. Clavel C, Zerat L, Binninger I, Boutterin M C, Polette M, Monsonego J, et al. DNA content measurement and in situ hybridization in condylomatous cervical lesions. Diagn Mol Pathol 1992;1:180-4.
19. Del Mistro A, Koss LG, Braunstein J, Bennett B, Saccomano G, Simmons KM. Condylomata acuminata of the urinary bladder. Am J Surg Pathol 1988,12:205-15.
20. Evans AS, Monaghan JM. Nuclear DNA content of normal, neoplastic and "wart affected" cervical biopsies. Anal Quant Cytol Histol 1983;5:112-16.
21. Fu YS, Braun L, Shah KV, Lawrence WD, Robboy SJ. Histologic, nuclear DNA and human papillomavirus studies of cervical condylomas. Cancer 1983;52:1705-11.
22. Fu YS, Reagan JW, Richart RM. Definition of precursors. Gynecol Oncol 1981;12:S220-31.
23. Fujii T, Crum CP, Winkler B, Fu YS, Richart RM. Human papillomavirus infection and cervical intraepithelial neoplasia: histopathology and DNA content. Obstet Gynecol 1984;63:99-104.
24. Reid R, Crum CP, Herschmann BR, Fu YS, Braun L, Shah KV, et al. Genital warts and cervical cancer III: subclinical and papillomaviral infection and cervical neoplasia are linked by a spectrum of continuous morphologic and biologic change. Cancer 1984;53:49-53.
25. Schevchuk MM, Richart RM. DNA content of condyloma acuminatum. Cancer 1982;49:489-92.
26. 35S based methodologies for the detection of human papillomavirus DNA by in situ hybridization. J Virol Methods 1991;33: 253-66.
27. Cooper K, Herrington CS, Stickland JE, Evans MF, O'D McGee J. Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation. J Clin Pathol 1991;44:990-6.
28. Binninger I, Clavel C, Polette M, Boutterin MC, Chypre C, Alpha B, et al. A new non isotopic detection of human papillomavirus DNA using polymerase chain reaction. Diagn Mol Pathol 1992;1:239-45.
29. Lorenzato M, Lallemand A, Visseaux-Coletto B, Gaillard D. Quantification de l1ADN par analyse d'image sur coupes en paraffine. Ann Pathol 1994;14:257-60.
30. Pei XF, Gorman PA, Watt FM. Two strains of human keratinocytes transfected with HPV 16 DNA: comparison with the normal parental cells. Carcinogenesis 1991;12:277-84.
31. Hurlin PJ, Kaur P, Smith PP, Perez-Reyes N, Blanton RA, McDougall JK. Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype. Proc Natl Acad Sci USA 1991;88:570-4.
32. Gilles C, Piette J, Rombouts S, Laurent C, Foidart JM. Immortalization of human cervical keratinocytes by human papillomavirus type 33. Int J Cancer 1993;53:872-9.
33. Herman CJ. Cytometric DNA analysis in the management of cancer. Cancer 1992;69:1553-6.